Treatment patterns for patients with BRCA1/2-positive metastatic castration-resistant prostate cancer.
Patients with BRCA-positive metastatic castration-resistant prostate cancer (mCRPC) have an aggressive disease course. This study aimed to describe real-world treatment patterns among patients with BRCA-positive mCRPC. De-identified electronic health …